A Clinical Study to Assess the Effect of Hair Care Products on Grey Hair and Overall Hair Health (NCT07123636) | Clinical Trial Compass
CompletedNot Applicable
A Clinical Study to Assess the Effect of Hair Care Products on Grey Hair and Overall Hair Health
United States70 participantsStarted 2023-11-01
Plain-language summary
This is a 24-week virtual, single-arm study designed to evaluate the effectiveness of a hair care system-comprising the "Not Today, Grey" supplement, "To the Root" scalp serum, "Wash" shampoo, and "Smooth" conditioner-on grey hair reduction and overall hair health. Assessments include clinical grading of photographic evidence by dermatologists and participant-reported outcomes.
Who can participate
Age range25 Months – 55 Months
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female (35% male and 65% female)
* Aged 25-55
* Must experience 5-25% of hair being grey as confirmed by a dermatologist grading of the baseline photo (see Figure 1 below)
* Any hair color that the investigator can clearly distinguish grey hairs from the natural hair color.
* Individuals who have not dyed or highlighted their hair for at least 6 months prior to screening/baseline and who agree to refrain from dyeing the hair until after the final study visit.
* Willing to maintain the same hairstyle and length.
* Willing to refrain from using any topical hair products (other than Wash, Smooth, and To The Root) or treatments on the hair that could affect hair properties (e.g., heat treatments other than blowdrying, medicated shampoo) for the duration of the study.
* Willing to refrain from taking any vitamins, minerals, or herbal supplements with claims related to hair growth or benefits during the study and to not start taking any new vitamins, minerals, or supplements of any kind during the study.
* Willing to comply with the protocol, take all required photos, and immediately report any changes in health status or medications, adverse events, symptoms, or reactions.
* Willing and able to provide written informed consent, including an agreement to privacy language compliant with country and/or local requirements, after the scope and nature of the investigation have been explained and before the initiation of any study-related procedures.
* Must…